Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.

× No keyword cloud information.

6 in total

1. The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34+ progenitor cells.

Authors: Brigitte Mohr; Uta Oelschlaegel; Christian Thiede; Michelle Meredyth Stewart; Gerhard Ehninger; Uwe Platzbecker
Journal: Haematologica Date: 2009-01-30 Impact factor: 9.941

2. Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

Authors: Mario Cazzola
Journal: Haematologica Date: 2009-08 Impact factor: 9.941

3. Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell study.

Authors: Laurent Garderet; Ladan Kobari; Christelle Mazurier; Caroline De Witte; Marie-Catherine Giarratana; Christine Pérot; Norbert Claude Gorin; Hélène Lapillonne; Luc Douay
Journal: Haematologica Date: 2009-10-08 Impact factor: 9.941

4. Durable response to lenalidomide in a patient with myelodysplastic syndrome associated with isolated 5q deletion and JAK2 V617F mutation despite discontinuation of treatment.

Authors: Eleftheria Hatzimichael; Konstantinos Lagos; Amalia Vassou; Dora Gougopoulou; Alexandra Papoudou-Bai; Evangelos Briasoulis
Journal: Mol Clin Oncol Date: 2016-04-20

5. Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion.

Authors: Vu H Duong; Rami S Komrokji; Alan F List
Journal: Ther Adv Hematol Date: 2012-04

6. Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway.

Authors: Ota Fuchs
Journal: Leuk Res Treatment Date: 2012-02-13

6 in total